Premium HealthCare UK Dihydrocodeine 300mg is a semi-synthetic opioid analgesic studied for pain management and opioid receptor pharmacology research.
Key Details
– 100 tablets x 300mg
– Oral administration
Research Benefits
– Semi-synthetic opioid derived from codeine
– Agonist activity at mu, delta, and kappa opioid receptors
– Studied for moderate to severe pain management research
– Antitussive properties and respiratory research applications
– Comparative pharmacology versus codeine and morphine
Suggested Research Protocol
– Dose: Research protocol dependent
– Opioid receptor research applications
Quality Assurance: Pharmaceutical grade, batch verified.
Reviews
There are no reviews yet.